| Active Ingredient | ADRENALINE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | Acute bronchospasm. Emergency treatment of asthma and anaphylaxis, cardiac arrest. |
| Caution | Cardiac arrhythmias, tachycardia, tremor, anxiety . Avoid in the elderly and patients with heart disease. |
| Dose Range | 0.5-1mg s.c. or i.m. |
| Drug Interactions | |
| Pregnancy | May reduce placental perfusion and cause tachycardia, cardiac irregularities, an More ... |
| Breast Feeding | Present in milk but unlikely to be harmful as poor oral bioavailability. |
| Active Ingredient | EPHEDRINE HYDROCHLORIDE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | Reversal of hypotension from spinal or epidural anaesthesia |
| Caution |
Anginal pain; anxiety; arrhythmias; flushing; headache; hypersalivation. |
| Dose Range | 3-6 mg every 3-4 minutes (max. p er dose 9 mg), adjusted according to response, injection solution to contain ephedrine hydrochloride 3 mg/ml; maximum 30 mg p er course. |
| Drug Interactions | |
| Pregnancy | Increased fetal heart rate has been reported. Use with caution during pregnancy. |
| Breast Feeding |
| Active Ingredient | NORADRENALINE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | |
| Caution | |
| Dose Range | |
| Drug Interactions | |
| Pregnancy | |
| Breast Feeding |
| Active Ingredient | PSEUDOEPHEDRINE |
| Therapeutic Class | ALPHA & BETA ADRENERGIC AGONIST |
| Indications | Symptomatic relief of nasal congestion. |
| Caution | Tachycardia, anxiety, restlessness, and insomnia. |
| Dose Range | Adults and children over 12 years: 60mg every 4-6 hours to a maximum of 4 doses in 24 hours; patients with renal dysfunction should have dose adjustments. Pediatric: 6-12 years: 30mg 3-4 times daily. |
| Drug Interactions | |
| Pregnancy | Pseudoephedrine should be avoided during pregnancy because of the severity of th More ... |
| Breast Feeding | May suppress lactation; avoid if lactation is not well established or if milk pr More ... |